These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum. Tzavara ET; Valjent E; Firmo C; Mas M; Beslot F; Defer N; Roques BP; Hanoune J; Maldonado R Eur J Neurosci; 2000 Mar; 12(3):1038-46. PubMed ID: 10762335 [TBL] [Abstract][Full Text] [Related]
25. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. Compton DR; Aceto MD; Lowe J; Martin BR J Pharmacol Exp Ther; 1996 May; 277(2):586-94. PubMed ID: 8627535 [TBL] [Abstract][Full Text] [Related]
26. The impact of gonadal hormones on cannabinoid dependence. Marusich JA; Craft RM; Lefever TW; Wiley JL Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of sex differences in cannabinoid dependence. Marusich JA; Lefever TW; Antonazzo KR; Craft RM; Wiley JL Drug Alcohol Depend; 2014 Apr; 137():20-8. PubMed ID: 24582909 [TBL] [Abstract][Full Text] [Related]
28. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Diana M; Melis M; Muntoni AL; Gessa GL Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10269-73. PubMed ID: 9707636 [TBL] [Abstract][Full Text] [Related]
29. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. Adams IB; Compton DR; Martin BR J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885 [TBL] [Abstract][Full Text] [Related]
30. Attenuation of delta 9-tetrahydrocannabinol-induced withdrawal-like behaviour by delta 9-tetrahydrocannabinol. Verberne AJ; Taylor DA; Fennessy MR Psychopharmacology (Berl); 1981; 73(1):97-8. PubMed ID: 6262850 [TBL] [Abstract][Full Text] [Related]
31. Marijuana withdrawal syndrome in the animal model. Lichtman AH; Martin BR J Clin Pharmacol; 2002 Nov; 42(S1):20S-27S. PubMed ID: 12412832 [TBL] [Abstract][Full Text] [Related]
33. "Antagonist"-precipitated withdrawal in the rat after chronic delta9-tetrahydrocannabinol treatment. Taylor DA; Fennessy MR J Pharm Pharmacol; 1978 Oct; 30(10):654-6. PubMed ID: 30825 [No Abstract] [Full Text] [Related]
34. The effect of delta-9-tetrahydrocannabinol on barbiturate withdrawal convulsions in the rat. Gildea ML; Bourn WM Life Sci; 1977 Sep; 21(6):829-32. PubMed ID: 562463 [No Abstract] [Full Text] [Related]
35. Nicotine and Delta(9)-tetrahydrocannabinol withdrawal induce Narp in the central nucleus of the amygdala. Reti IM; Han S; Miskimon M; Rosen JB; Baraban JM Synapse; 2009 Mar; 63(3):252-5. PubMed ID: 19084905 [TBL] [Abstract][Full Text] [Related]